TRIPTODUR

Azurity Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Dec 15, 2022
Approval ID: f41380e7-b830-432d-a5f5-a872932f107e
Products: 1 registered
Version: 13

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TRIPTODUR safely and effectively. See full prescribing information for TRIPTODUR. TRIPTODUR (triptorelin) for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2000

Quick Stats

Total Products1

Labelers2

Label Sections38

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.